Compare FLNT & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLNT | XTNT |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | United States |
| Employees | 208 | N/A |
| Industry | Advertising | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.5M | 88.7M |
| IPO Year | 2009 | 2009 |
| Metric | FLNT | XTNT |
|---|---|---|
| Price | $3.68 | $0.56 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $3.50 | $1.50 |
| AVG Volume (30 Days) | 44.6K | ★ 118.3K |
| Earning Date | 03-09-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $254,623,000.00 | $53,337,000.00 |
| Revenue This Year | $8.67 | $15.08 |
| Revenue Next Year | $14.05 | N/A |
| P/E Ratio | ★ N/A | $18.77 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.50 | $0.34 |
| 52 Week High | $4.15 | $0.95 |
| Indicator | FLNT | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 48.99 | 42.28 |
| Support Level | $2.92 | $0.55 |
| Resistance Level | $3.83 | $0.68 |
| Average True Range (ATR) | 0.42 | 0.05 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 38.98 | 10.21 |
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.